Characterization of solute binding at human serum albumin site II and its geometry using a biochromatographic approach

Biophysical Journal

Volumn 77, Issue 3, 1999, Pages 1206-1212

  Peyrin, E ^a   Guillaume, Y C ^a   Guinchard, C ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; HUMAN SERUM ALBUMIN; NORVALINE; SODIUM DIHYDROGEN PHOSPHATE; SODIUM ION; SOLVENT; TRYPTOPHAN DERIVATIVE;

ARTICLE; BINDING SITE; CHIRALITY; HYDROPHOBICITY; MODEL; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PROTEIN BINDING; STEREOCHEMISTRY; SURFACE CHARGE;

EID: 0032872988     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(99)76972-9     Document Type: Article

References (41)

1. Allenmark, S., B. Bomgren, and H. Boren. 1984. Direct liquid Chromatographic Separation of enantiomers on immobilized protein stationary phases. IV. Molecular interaction forces and retention behavior in chromatography on bovine serum albumin as a stationary phase. J. Chromatogr. 316:617-624.
2. Armstrong, D. W., Y. Tang, S. Chen, Y. Zhou, C. Bagwill, and J-R. Chen. 1994. Macrocyclic antibiotics as a new class of chiral selectors for liquid chromatography. Anal. Chem. 66:1473-1484.
3. Back, J. F., F. Oakenfull, and M. B. Smith. 1979. Increased thermal stability of proteins in the presence of sugars and polyols. Biochemistry. 18:5191-5196.
4. Bard, A. J., and L. R. Faulkner. 1981. Electrochemical Methods. John Wiley and Sons, New York.
5. Bevington, P. R. 1969. Data Reduction and Error Analysis for the Physical Sciences. Mcgraw-Hill, New York.
6. Bree, F., P. Nguyen, E. Albengres, S. Urien, P. Riant, P. G. Welling, and J. P. Tillement. 1989. Evidence for isoxicam binding to site I as a primary site and to site II as a secondary site of human serum albumin. Biochem. Pharmacol. 38:753-758.
7. Chattopadhyay, A., T. Tian, L. Kortum, and D. S. Hage. 1998. Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography. J. Chromalogr. B. 715:183-190.
8. Deschamps-Labat, L., F. Pehourcq, M. Jagou, and B. Bannwarth. 1997. Relationship between lipophilicity and binding to human serum albumin of arylpropionic acid non-steroidal anti-inflammatory drugs. J. Pharm. Biomed. Anal. 16:223-229.
9. Dill, K. A. 1990. Dominant forces in protein folding. Biochemistry. 29: 7133-7154.
10. Fehske, K. J., W. E. Muller, and V. Wollert. 1981. The location of drug binding sites in human serum albumin. Biochem. Pharmacol. 30:687-692.
11. Guillaume, Y. C., and C. Guinchard. 1997. A new statistical approach to a gas chromatography retention model: application to dichlorophenol isomers. J. Phys. Chem. 101:8390-8394 (1997).
12. Hage, D. S., and S. A. Tweed. 1997. Recent advances in Chromatographic and electrophoretic methods for the study of drug-protein interactions. J. Chromatogr. B. 699:499-525.
13. He, X. M., and D. C. Carter. 1992. Atomic structure and chemistry of human serum albumin. Nature. 358:209-215.
14. 2+ to silica. Anal. Chem. 68: 4119-4123.
15. Janado, M., Y. Yano, M. Umura, and Y. Kondo. 1995. Differential interactions of cyclodextrins with hydrophobic derivatives of sepharose CL-4B. /. Solution. Chem. 24:587-599.
16. nd ed, Holt, Rinehart and Winston, New York.
17. Kaliszan, R., T. A. G. Noctor, and I. W. Wainer. 1992. Stereochemical aspects of benzodiazepine binding to human serum albumin. II. Quantitative relationships between structure and enantioselective retention in high performance liquid affinity chromatography. Mol. Pharmacol. 42: 512-517.
18. Kohita, H., Y. Matsushita, and I. Moriguchi. 1994. Binding of carprofen to human and bovine serum albumins. Chem. Pharm. Bull. 42:937-940.
19. Leckband, D. E., J. N. Israelachvili, F. J. Schmitt, and W. Knoll. 1992. Long-range attraction and molecular rearrangements in receptor-ligand interactions. Science. 255:1419-1421.
20. Loun, B., and D. S. Hage. 1994. Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. Anal. Chem. 66:3814-3822.
21. Marle, I., P. Erlandsson, L. Hansson, R. Isaksson, C. Petersson, and G. Petersson. 1991. Separation of enantiomers using cellulase (CBH I) silica as a chiral stationary phase. J. Chromatogr. 586:233-248.
22. Maruyama, T., C. C. Lin, K. Yamasaki, T. Miyoshi, T. Imai, M. Yamasaki, and M. Otagiri. 1993. Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group. Biochem. Pharmacol. 45: 1017-1026.
23. Muller, N., F. Lapicque, E. Drelon, and P. Netter. 1994. Binding sites fluorescent probes on human serum albumin. J. Pharm. Pharmacol. 46:300-304.
24. Peyrin, E., Y. C. Guillaume, and C. Guinchard. 1997. Interactions between dansyl amino acids and human serum albumin: mobile phase pH and temperature considerations. Anal. Chem. 69:4979-4984.
25. Peyrin, E., Y. C. Guillaume, N. Morin, and C. Guinchard. 1998a. Sucrose dependence of solute retention on human serum albumin stationary phase: hydrophobic effect and surface tension considerations. Anal. Chem. 70:2773-3102.
26. Peyrin, E., Y. C. Guillaume, and C. Guinchard. 1998b. Peculiarities of dansyl amino acid enantioselectivity using human serum albumin as a chiral selector. J. Chroinatogr. Sci. 36:97-103.
27. Peyrin, E., Y. C. Guillaume, N. Morin, and C. Guinchard. 1998c. Retention behavior of D, L-dansyl-amino acids on a human serum albumin stationary phase: effect of a mobile phase modifier. J. Chromatogr A. 808:113-120.
28. Peyrin, E., and Y. C. Guillaume. 1998d. Chiral discrimination of N-(dansyl)-DL-amino acids on human serum albumin stationary phase: effect of a mobile phase modifier. Chromatographia. 48:431-435.
29. Ross, P. D., and S. Subramanian. 1981. Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry. 20: 3096-3102.
30. Russeva, V., N. Stravreva, R. Rakovska, and D. Michailova. 1994. Binding of sulindac to human serum albumin studied by circular dichroism. Arzneim. Forsch. Drug Res. 44:159-162.
31. Schill, G., I. W. Wainer, and S. A. Barkan. 1986. Chiral separations of cationic and anionic drugs on an alpha 1-acid glycoprotein-bonded stationary phase (Enantiopac). II. Influence of mobile phase additives and pH on chiral resolution and retention. J. Chromatogr. 365:73-88.
32. Sebille, B., R. Zini, C. Vidal-Madjar, N. Thuaud, and J-P. Tillement. 1990. Separation procedures used to reveal and follow drug-protein binding. J. Chromatogr. 531:51-77.
33. Sudlow, G., D. J. Birkett, and D. N. Wade. 1975. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11:824-832.
34. Sudlow, G., D. J. Birkett, and D. N. Wade. 1976. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol 12:1052-1061.
35. Thompson, R. A., Z. Ge, N. Grinberg, D. Ellison, and P. Tway. 1995. Mechanistic aspects of the stereospecific interaction for aminoindanol with a crown ether column. Anal. Chem. 67:1580-1587.
36. Tweed, S. A., B. Loun, and D. S. Hage. 1997. Effects of ligand heterogeneity in the characterization of affinity columns by frontal analysis. Anal. Chem. 69:4790-4798.
37. van Oss, C. J. 1996. Forces interfaciales en milieux aqueux. Masson, Paris.
38. Vidal-Madjar, C., Jaulmes, A., Racine, M., and B. Sebille. 1988. Determination of binding constants by numerical simulation in zonal high-performance affinity chromatography. J. Chromatogr. 458:13-25.
39. Wanwilmolruk, S., D. J. Birkett, and P. M. Brooks. 1983. Structural requirements for drug binding to site II on human serum albumin. Mol. Pharmacol. 24:458-463.
40. Wirth, M. J., R. W. P. Fairbank, and H. O. Fatunmbi. 1997. Mixed self-assembled monolayers in chemical separations. Science. 275:44-47.
41. Yang, J., and D. S. Hage. 1997. Effect of mobile phase composition on the binding kinetics of chiral solutes on a protein-based high-performance liquid chromatography column: Interactions of D- and L-tryptophan with immobilized human serum albumin. J. Chromatogr. A. 766:15-25.